Clera - Your AI talent agent
Back to Companies
Nuvalent, Inc. logo

Nuvalent, Inc.

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv...

51-200 employees

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.

Frequently Asked Questions

How many employees does Nuvalent, Inc. have?

Nuvalent, Inc. has around 126 employees. As a Biotechnology Research company, they are actively growing their team with 0 open positions.

Why should I join Nuvalent, Inc.?

Nuvalent, Inc. is a leading Biotechnology Research company offering exciting career opportunities. With 0 open positions, now is a great time to join their growing team.

What does Nuvalent, Inc. do?

Nuvalent, Inc. is a Biotechnology Research company. Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in...